Generics in Brazil

Generics in Brazil

Code: ML-OHME4750 | Published: Jan-2016 | Pages: 31 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Brazil generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the generic-eligible market, are not included.

- The Brazilian generics market is expected to generate total revenues of $6.9bn in 2015, representing a compound annual growth rate (CAGR) of 16.6% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 28.2 % of total pharma volume in 2015.

- The sale of generic drugs is expected to outstrip the larger market, so much so that generics are expected to have a market share of nearly half by 2020.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil

Leading company profiles reveal details of key generics market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Brazil economy

Reasons To Buy
What was the size of the Brazil generics market by value in 2015?

What will be the size of the Brazil generics market in 2020?

What factors are affecting the strength of competition in the Brazil generics market?

How has the market performed over the last five years?

How large is Brazils generics market in relation to its regional counterparts?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market volume 10
Market Segmentation 11
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Market volume forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
O AchE LaboratOrios FarmacEuticos S.A. 20
EMS Sigma Pharma 21
Eurofarma LaboratOrios Ltda 22
Sanofi SA 23
Macroeconomic Indicators 26
Country Data 26
Methodology 28
Industry associations 29
Related MarketLine research 29
Appendix 30
About MarketLine 30

List of Tables
Table 1: Brazil generics market value: $ billion, 2011-15(e)
Table 2: Brazil generics market volume: % of total pharma volume, 2011-15(e)
Table 3: Brazil generics market geography segmentation: $ billion, 2015(e)
Table 4: Brazil generics market value forecast: $ billion, 2015-20
Table 5: Brazil generics market volume forecast: % of total pharma volume, 2015-20
Table 6: O AchE LaboratOrios FarmacEuticos S.A.: key facts
Table 7: EMS Sigma Pharma: key facts
Table 8: Eurofarma LaboratOrios Ltda: key facts
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: key financials ($)
Table 11: Sanofi SA: key financials (Euro)
Table 12: Sanofi SA: key financial ratios
Table 13: Brazil size of population (million), 2011-15
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 15: Brazil gdp (current prices, $ billion), 2011-15
Table 16: Brazil inflation, 2011-15
Table 17: Brazil consumer price index (absolute), 2011-15
Table 18: Brazil exchange rate, 2011-15

List of Figures
Figure 1: Brazil generics market value: $ billion, 2011-15(e)
Figure 2: Brazil generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: Brazil generics market geography segmentation: % share, by value, 2015(e)
Figure 4: Brazil generics market value forecast: $ billion, 2015-20
Figure 5: Brazil generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in Brazil, 2015
Figure 7: Drivers of buyer power in the generics market in Brazil, 2015
Figure 8: Drivers of supplier power in the generics market in Brazil, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2015
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2015
Figure 12: Sanofi SA: revenues and profitability
Figure 13: Sanofi SA: assets and liabilities
O AchE LaboratOrios FarmacEuticos S.A., EMS Sigma Pharma, Eurofarma LaboratOrios Ltda, Sanofi SA

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine